SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject4/3/2003 5:08:16 AM
From: nigel bates  Read Replies (1) of 625
 
Cambridge Antibody Tech Group PLC
01 April 2003
SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1) Name of company
Cambridge Antibody Technology

2) Name of shareholder having a major interest
Wellington Management Company, LLP

3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18
Non Beneficial

4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them

Interests held in various accounts (the 'Accounts') for which
Wellington Management Company acts as a discretionary investment manager
- names of the Accounts not disclosed.

5) Number of shares/amount of stock acquired
612,283

6) Percentage of issued class
1.68%

7) Number of shares/amount of stock disposed
Nil

8) Percentage of issued class
Nil

9) Class of security
Ordinary 10p shares

10) Date of transaction
Not disclosed

11) Date company informed
31 March 2003

12) Total holding following this notification
1,762,336

13) Total percentage holding of issued class following this notification
4.85%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext